The Foundation Fighting Blindness annual report, released this week, details another groundbreaking year in which Foundation-funded studies made great strides across the continuum of research that will one day cure blindness caused by retinal degenerative disease. That work included harnessing the power of gene and stem-cell therapies, partnering with pharmaceutical companies to develop new drug treatments, and working across the retinal science community to create clinical trial endpoints that will strengthen and speed the all-important clinical trials process.
Dear Friends of the FFB Jacksonville Chapter:
Welcome to the Jacksonville Area Chapter of the Foundation Fighting Blindness! My name is Adriann Keve, and I am proud and honored to serve as your chapter president. Our goal as a chapter is to provide support and outreach for people affected by retinal degenerative diseases and their loved ones while raising money for research for treatments and cures for retinal degenerative diseases.
Emerging treatments seek to replace or edit non-functioning vision cells
Sponsored by the Foundation Fighting Blindness Clinical Research Institute, ProgSTAR is boosting knowledge and therapy development for leading cause of inherited macular degeneration
Seattle summit will report on latest methods in gene and stem-cell therapies being developed to treat and cure blindness caused by retinal diseases